Hisun's capreomycin gets WHO prequalification
This article was originally published in Scrip
Executive Summary
The World Health Organization (WHO) has prequalified Zhejiang Hisun Pharmaceutical Co's capreomycin, the first second line anti-TB active pharmaceutical ingredient (API) for injectables to achieve this status.